Inhibition of glycosylation decreases Na+/H+ exchange activity, blocks NHE-3 transport to the membrane, and increases NHE-3 mRNA expression in LLC-PK1 cells

Manoocher Soleimani, Gurinder Singh, Crescence Bookstein, Mrinalini C. Rao, Eugene B. Chang, Jesus Dominguez

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Recent studies have shown that NHE-3 is the luminal Na+/H+ exchanger isoform in cultured renal proximal tubule cells LLC-PK1 and OK (J Biol Chem 1994;269:15613-8). The purpose of the current experiments was to study the role of NHE-3 glycosylation on antiporter activity in LLC-PK1 cells. Treatment of LLC-PK1 cells with 1.5 μg/ml tunicamycin for 24 hours, which blocks glycosylation in the endoplasmic reticulum, significantly decreased antiporter activity as assessed by acid-stimulated sodium 22 uptake (9.52 ± 1.0 nmol/mg protein in control cells vs 5.85 ± 0.7 nmol/mg protein in tunicamycin-treated cells, p <0.01, n = 4) and sodium-dependent pH1 recovery from an acid load (0.46 ± 0.05 pH/min in control cells vs 0.35 ± 0.04 pH/min in tunicamycin-treated cells, p <0.02, n = 6). Lactate dehydrogenase (LDH) concentration in the medium was the same in both groups (p > 0.05), indicating that the inhibitory effect of tunicamycin was not caused by cell toxicity. Northern hybridization of poly(A)+ RNA from LLC- PK1 cells illustrated that in tunicamycin-treated cells, NHE-3 mRNA expression increased threefold over control cells. Immunoblots of luminal membranes from control LLC-PK1 cells with specific NHE-3 antiserum showed a doublet at 94 to 95 kd and a band at 90 kd. Luminal membranes from tunicamycin-treated cells showed only one strong band at 95 kd. NHE-3 immunoblots of whole cell extract from tunicamycin-treated cells showed that in addition to the 95 kd protein, an 87 kd band was also detected. These results are consistent with the possibility that the two bands in the 94 and 90 kd areas became deglycosylated and did not reach the membrane in the presence of tunicamycin. We conclude that glycosylation of the Na+/H+ exchanger isoform NHE-3 is essential for antiporter activity in LLC-PK1 cells. The results further suggest that glycosylation of NHE-3 mediates the translocation and insertion of this exchanger in the plasma membrane.

Original languageEnglish (US)
Pages (from-to)565-573
Number of pages9
JournalJournal of Laboratory and Clinical Medicine
Volume127
Issue number6
DOIs
StatePublished - Jun 1996
Externally publishedYes

Fingerprint

LLC-PK1 Cells
Glycosylation
Tunicamycin
Membranes
Messenger RNA
Antiporters
Cells
Sodium-Hydrogen Antiporter
Protein Isoforms
Proximal Kidney Tubule
Proteins
Cell membranes
Cell Extracts
Endoplasmic Reticulum
Toxicity
Immune Sera
Sodium
Cell Membrane
Acids

ASJC Scopus subject areas

  • Medicine(all)
  • Pathology and Forensic Medicine

Cite this

Inhibition of glycosylation decreases Na+/H+ exchange activity, blocks NHE-3 transport to the membrane, and increases NHE-3 mRNA expression in LLC-PK1 cells. / Soleimani, Manoocher; Singh, Gurinder; Bookstein, Crescence; Rao, Mrinalini C.; Chang, Eugene B.; Dominguez, Jesus.

In: Journal of Laboratory and Clinical Medicine, Vol. 127, No. 6, 06.1996, p. 565-573.

Research output: Contribution to journalArticle

Soleimani, Manoocher ; Singh, Gurinder ; Bookstein, Crescence ; Rao, Mrinalini C. ; Chang, Eugene B. ; Dominguez, Jesus. / Inhibition of glycosylation decreases Na+/H+ exchange activity, blocks NHE-3 transport to the membrane, and increases NHE-3 mRNA expression in LLC-PK1 cells. In: Journal of Laboratory and Clinical Medicine. 1996 ; Vol. 127, No. 6. pp. 565-573.
@article{c0d394ada12c44e4b7d437faf88dd52a,
title = "Inhibition of glycosylation decreases Na+/H+ exchange activity, blocks NHE-3 transport to the membrane, and increases NHE-3 mRNA expression in LLC-PK1 cells",
abstract = "Recent studies have shown that NHE-3 is the luminal Na+/H+ exchanger isoform in cultured renal proximal tubule cells LLC-PK1 and OK (J Biol Chem 1994;269:15613-8). The purpose of the current experiments was to study the role of NHE-3 glycosylation on antiporter activity in LLC-PK1 cells. Treatment of LLC-PK1 cells with 1.5 μg/ml tunicamycin for 24 hours, which blocks glycosylation in the endoplasmic reticulum, significantly decreased antiporter activity as assessed by acid-stimulated sodium 22 uptake (9.52 ± 1.0 nmol/mg protein in control cells vs 5.85 ± 0.7 nmol/mg protein in tunicamycin-treated cells, p <0.01, n = 4) and sodium-dependent pH1 recovery from an acid load (0.46 ± 0.05 pH/min in control cells vs 0.35 ± 0.04 pH/min in tunicamycin-treated cells, p <0.02, n = 6). Lactate dehydrogenase (LDH) concentration in the medium was the same in both groups (p > 0.05), indicating that the inhibitory effect of tunicamycin was not caused by cell toxicity. Northern hybridization of poly(A)+ RNA from LLC- PK1 cells illustrated that in tunicamycin-treated cells, NHE-3 mRNA expression increased threefold over control cells. Immunoblots of luminal membranes from control LLC-PK1 cells with specific NHE-3 antiserum showed a doublet at 94 to 95 kd and a band at 90 kd. Luminal membranes from tunicamycin-treated cells showed only one strong band at 95 kd. NHE-3 immunoblots of whole cell extract from tunicamycin-treated cells showed that in addition to the 95 kd protein, an 87 kd band was also detected. These results are consistent with the possibility that the two bands in the 94 and 90 kd areas became deglycosylated and did not reach the membrane in the presence of tunicamycin. We conclude that glycosylation of the Na+/H+ exchanger isoform NHE-3 is essential for antiporter activity in LLC-PK1 cells. The results further suggest that glycosylation of NHE-3 mediates the translocation and insertion of this exchanger in the plasma membrane.",
author = "Manoocher Soleimani and Gurinder Singh and Crescence Bookstein and Rao, {Mrinalini C.} and Chang, {Eugene B.} and Jesus Dominguez",
year = "1996",
month = "6",
doi = "10.1016/S0022-2143(96)90147-X",
language = "English (US)",
volume = "127",
pages = "565--573",
journal = "Translational Research",
issn = "1931-5244",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - Inhibition of glycosylation decreases Na+/H+ exchange activity, blocks NHE-3 transport to the membrane, and increases NHE-3 mRNA expression in LLC-PK1 cells

AU - Soleimani, Manoocher

AU - Singh, Gurinder

AU - Bookstein, Crescence

AU - Rao, Mrinalini C.

AU - Chang, Eugene B.

AU - Dominguez, Jesus

PY - 1996/6

Y1 - 1996/6

N2 - Recent studies have shown that NHE-3 is the luminal Na+/H+ exchanger isoform in cultured renal proximal tubule cells LLC-PK1 and OK (J Biol Chem 1994;269:15613-8). The purpose of the current experiments was to study the role of NHE-3 glycosylation on antiporter activity in LLC-PK1 cells. Treatment of LLC-PK1 cells with 1.5 μg/ml tunicamycin for 24 hours, which blocks glycosylation in the endoplasmic reticulum, significantly decreased antiporter activity as assessed by acid-stimulated sodium 22 uptake (9.52 ± 1.0 nmol/mg protein in control cells vs 5.85 ± 0.7 nmol/mg protein in tunicamycin-treated cells, p <0.01, n = 4) and sodium-dependent pH1 recovery from an acid load (0.46 ± 0.05 pH/min in control cells vs 0.35 ± 0.04 pH/min in tunicamycin-treated cells, p <0.02, n = 6). Lactate dehydrogenase (LDH) concentration in the medium was the same in both groups (p > 0.05), indicating that the inhibitory effect of tunicamycin was not caused by cell toxicity. Northern hybridization of poly(A)+ RNA from LLC- PK1 cells illustrated that in tunicamycin-treated cells, NHE-3 mRNA expression increased threefold over control cells. Immunoblots of luminal membranes from control LLC-PK1 cells with specific NHE-3 antiserum showed a doublet at 94 to 95 kd and a band at 90 kd. Luminal membranes from tunicamycin-treated cells showed only one strong band at 95 kd. NHE-3 immunoblots of whole cell extract from tunicamycin-treated cells showed that in addition to the 95 kd protein, an 87 kd band was also detected. These results are consistent with the possibility that the two bands in the 94 and 90 kd areas became deglycosylated and did not reach the membrane in the presence of tunicamycin. We conclude that glycosylation of the Na+/H+ exchanger isoform NHE-3 is essential for antiporter activity in LLC-PK1 cells. The results further suggest that glycosylation of NHE-3 mediates the translocation and insertion of this exchanger in the plasma membrane.

AB - Recent studies have shown that NHE-3 is the luminal Na+/H+ exchanger isoform in cultured renal proximal tubule cells LLC-PK1 and OK (J Biol Chem 1994;269:15613-8). The purpose of the current experiments was to study the role of NHE-3 glycosylation on antiporter activity in LLC-PK1 cells. Treatment of LLC-PK1 cells with 1.5 μg/ml tunicamycin for 24 hours, which blocks glycosylation in the endoplasmic reticulum, significantly decreased antiporter activity as assessed by acid-stimulated sodium 22 uptake (9.52 ± 1.0 nmol/mg protein in control cells vs 5.85 ± 0.7 nmol/mg protein in tunicamycin-treated cells, p <0.01, n = 4) and sodium-dependent pH1 recovery from an acid load (0.46 ± 0.05 pH/min in control cells vs 0.35 ± 0.04 pH/min in tunicamycin-treated cells, p <0.02, n = 6). Lactate dehydrogenase (LDH) concentration in the medium was the same in both groups (p > 0.05), indicating that the inhibitory effect of tunicamycin was not caused by cell toxicity. Northern hybridization of poly(A)+ RNA from LLC- PK1 cells illustrated that in tunicamycin-treated cells, NHE-3 mRNA expression increased threefold over control cells. Immunoblots of luminal membranes from control LLC-PK1 cells with specific NHE-3 antiserum showed a doublet at 94 to 95 kd and a band at 90 kd. Luminal membranes from tunicamycin-treated cells showed only one strong band at 95 kd. NHE-3 immunoblots of whole cell extract from tunicamycin-treated cells showed that in addition to the 95 kd protein, an 87 kd band was also detected. These results are consistent with the possibility that the two bands in the 94 and 90 kd areas became deglycosylated and did not reach the membrane in the presence of tunicamycin. We conclude that glycosylation of the Na+/H+ exchanger isoform NHE-3 is essential for antiporter activity in LLC-PK1 cells. The results further suggest that glycosylation of NHE-3 mediates the translocation and insertion of this exchanger in the plasma membrane.

UR - http://www.scopus.com/inward/record.url?scp=0030174563&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030174563&partnerID=8YFLogxK

U2 - 10.1016/S0022-2143(96)90147-X

DO - 10.1016/S0022-2143(96)90147-X

M3 - Article

C2 - 8648261

AN - SCOPUS:0030174563

VL - 127

SP - 565

EP - 573

JO - Translational Research

JF - Translational Research

SN - 1931-5244

IS - 6

ER -